Metagenomi Therapeutics, Inc. Share Price & Technical Analysis
MGX · $1.34 (-0.74%)
Healthcare / Biotechnology
$1.34
-0.74%
Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for t…
Price chart
Seasonality
May has 0 positive and 1 negative years (last 3 years shown)
0% return in May, -4% avg return in past 3 year May month.
-20% return in 2026, -40% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -6% | 0% | -13% | 0% | 0% | – | – | – | – | – | – | – | -20% |
| 25 | -27% | -23% | -30% | 21% | 0% | -12% | 53% | -23% | 33% | 9% | -28% | -6% | -32% |
| 24 | – | 17% | -10% | -36% | -9% | -36% | -2% | -21% | -27% | -9% | 5% | 80% | -48% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$50.82M
P/E ratio
—
52W high
$3.95
52W low
$1.24
Volume
1,18,862
Beta
0.65
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Metagenomi Therapeutics, Inc. share price today?
- Metagenomi Therapeutics, Inc. (MGX) last traded around $1.34 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MGX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MGX. Download the app for real-time alerts.
- How can I analyze Metagenomi Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.